Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes and Mutational Profile Associated with Dysmyelopoiesis in Chronic Myelomonocytic Leukemia

Xavier Calvo, David Román, Nieves Garcia Garcia-Gisbert, Concepción Fernández-Rodriguez, Marta Salido, Anna Puiggros, Blanca Espinet, Sara Garcia-Avila, Félix López Cadenas, Abora Rial-Villavecchia, Luis Colomo, Lourdes Florensa, Ana Ferrer, Leonor Arenillas

Blood (2023) 142 (Supplement 1): 3226.

https://doi.org/10.1182/blood-2023-185591

Published: 2023

Journal Articles

Assessment of Dysgranulopoiesis By Optical Cytology Compared to Distribution of Monocyte Subsets By Flow Cytometry in Peripheral Blood for Predicting the Diagnosis of CMML

David Roman-Bravo, Leonor Arenillas, Aylin Vasquez, Lourdes Florensa, Beatriz Costan, Rosa Navarro, Martina Karasiewicz, Sara Garcia-Avila, Felix Lopez-Cadenas, Marta Salido, Anna Puiggros, Blanca Espinet, Ana Ferrer, Xavier Calvo

Blood (2022) 140 (Supplement 1): 12347–12348.

https://doi.org/10.1182/blood-2022-166229

Published: 2022

Journal Articles

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

David Roman-Bravo, Leonor Arenillas, Maria Teresa Asensi, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Brayan Merchan, Sara García Ávila, Beatriz Bellosillo, Concepción Fernández-Rodríguez, Lourdes Florensa, Ana Ferrer, Xavier Calvo

Blood (2021) 138 (Supplement 1): 1533.

https://doi.org/10.1182/blood-2021-146447

Published: 2021

Journal Articles

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Xavier Calvo, MD PhD, Ivonne Parraga, Fellow, Nieves Garcia-Gisbert, MSc, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade Campos, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 5437.

https://doi.org/10.1182/blood-2019-130499

Published: 2019

Journal Articles

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

David Roman, MD, Leonor Arenillas, MD PhD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Marta Salido, PhD, Puiggros Anna, Blanca Espinet, PhD, Lluís Colomo, MD PhD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Xavier Calvo, MD PhD

Blood (2019) 134 (Supplement_1): 4262.

https://doi.org/10.1182/blood-2019-128768

Published: 2019

Journal Articles

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Xavier Calvo, MD PhD, Nieves Garcia-Gisbert, MSc, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca, MD, Concepción Fernández, Marta Salido, PhD, Anna Puiggros, PhD, Blanca Espinet, PhD, Beatriz Bellosillo, PhD, Lluís Colomo, MD PhD, David Roman, MD, Marcio Andrade, MD PhD, Brayan Merchan, MD MSc, Ana Ferrer, MD PhD, Leonor Arenillas, MD PhD

Blood (2019) 134 (Supplement_1): 4266.

https://doi.org/10.1182/blood-2019-130445

Published: 2019

Journal Articles

Diagnostic Utility of Flow Cytometric Immunophenotyping in Chronic Myelomonocytic Leukemia

Leonor Arenillas, MD PhD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca Romero, MD, Anna Puiggros, PhD, Marta Salido, PhD, Blanca Espinet, PhD, Anna Angona, MD PhD, Ana Ferrer, MD PhD, Carme Pedro, MD, Xavier Calvo, MD

Blood (2018) 132 (Supplement 1): 5526.

https://doi.org/10.1182/blood-2018-99-119689

Published: 2018

Journal Articles

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia

Xavier Calvo, MD, Ivonne Parraga, Fellow, Lourdes Florensa, MD PhD, Sara Montesdeoca Romero, MD, Anna Puiggros, PhD, Marta Salido, PhD, Blanca Espinet, PhD, Anna Angona, MD PhD, Ana Ferrer, MD PhD, Carme Pedro, MD, Leonor Arenillas, MD PhD

Blood (2018) 132 (Supplement 1): 5520.

https://doi.org/10.1182/blood-2018-99-119906

Published: 2018

Journal Articles

Considering Bone Marrow Blasts from Nonerythroid Cells Improves the Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2016) 128 (22): 1991.

https://doi.org/10.1182/blood.V128.22.1991.1991

Published: 2016

Journal Articles

Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Blood (2016) 128 (22): 3185.

https://doi.org/10.1182/blood.V128.22.3185.3185

Published: 2016

Journal Articles

Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts

Leonor Arenillas, MD, Xavier Calvo, MD, Mar Tormo, MD PhD, David Valcárcel, MD PhD, Elisa Luño, MD PhD, Esther Alonso, MD, María Consuelo Cañizo, MD PhD, Fernando Ramos, MD PhD MPH, Carmen Pedro, MD PhD, Beatriz Arrizabalaga, MD, Alicia Bailén, MD, José María Raya, MD, María Teresa Ardanaz, MD, Guillermo Sanz, MD PhD, Lourdes Florensa, MD PhD

Blood (2015) 126 (23): 2894.

https://doi.org/10.1182/blood.V126.23.2894.2894

Published: 2015

Journal Articles

The Complete Mutatome and Clonal Architecture of Del(5q)

Vera Ademà, MSc, Laura Palomo, MSc, Przychodzen P Bartlomiej, Diez-campelo Maria, MD, Naoko Hosono, MD PhD, Mar Mallo, PhD, Blanca Xicoy, MD PhD, Elisa Luño, Bhumika J. Patel, Cassandra M Hirsch, Lurdes Zamora, PhD, Thomas LaFramboise, PhD, Leonor Arenillas, MD, Albert Perez-Ladaga, PhD, Carme Pedro, Michael J. Clemente, Joan Bargay, MD, Julia Montoro, MD, Juan Carlos Caballero, MD, Brayan Merchan, MD, Victor Noriega, MD, Victor Marcos-Betes, MD, Consuelo Del Cañizo, MD PhD, Rosario Lopez, PhD, José María Raya, MD, Joaquin Sanchez-Garcia, MD, Eduardo Rios, Montserrat Arnan, MD PhD, Lourdes Florensa, MD PhD, Raquel de Paz, Angelina Lemes, MD, Paula Gomez-Marzo, MSc, Nuri Haro, Francisco Fuster-Tormo, MSc, Monica Bayes, PhD, Ivo Gut, Rafael Bejar, MDPhD, Mikkael A. Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD, Francesc Sole, PhD

Blood (2015) 126 (23): 608.

https://doi.org/10.1182/blood.V126.23.608.608

Published: 2015

Journal Articles

RAEB-1 with Erythroid Hyperplasia and Erythroleukemia Share Clinico-Biological Features and Outcome: A Same Disease with Different Labels?

Xavier Calvo, MD, Leonor Arenillas, MD, Mar Tormo, MD PhD, David Valcárcel, MD PhD, Elisa Luño, MD PhD, Esther Alonso, MD, María Díez-Campelo, MD PhD, Fernando Ramos, MD PhD MPH, Carmen Pedro, MD PhD, Beatriz Arrizabalaga, MD, Alicia Bailén, MD, José María Raya, MD, María Teresa Ardanaz, MD, Guillermo Sanz, MD PhD, Lourdes Florensa, MD PhD

Blood (2015) 126 (23): 2866.

https://doi.org/10.1182/blood.V126.23.2866.2866

Published: 2015

Journal Articles

Whole-Exome Sequencing in Myelodysplastic Syndromes with 5q Deletion

Blood (2014) 124 (21): 4635.

https://doi.org/10.1182/blood.V124.21.4635.4635

Published: 2014

Journal Articles

Giant multilobated mastocytes (promastocytes) in the setting of a refractory acute myeloid leukemia with myelodysplasia-related changes and monosomal karyotype

Francisco Jose Ortuño, Lourdes Florensa

Blood (2014) 123 (9): 1292.

https://doi.org/10.1182/blood-2013-11-540724

Published: 2014

Journal Articles

Whole-Exome Sequencing In Myelodysplastic Syndromes With 5q- and Normal Karyotype

Blood (2013) 122 (21): 1551.

https://doi.org/10.1182/blood.V122.21.1551.1551

Published: 2013

Journal Articles

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Jose Tomas Navarro, MD; PhD, Maria Rozman, MD, PhD, Leonor Arenillas, Ana Aventin, Teresa Gimenez, MD, Esther Alonso, MD, PhD, Granada Perea, MD; PhD, Mireia Camós, MD, PhD, Mayda Navarrete, MD, Esperanza Tuset, MD, Lourdes Florensa, MD, Fuensanta Millá, MD, PhD, Josep F Nomdedeu, MD, Esmeralda de la Banda, MD, Marina Díaz-Beyá, MD, Salut Brunet, Jorge Sierra, MD, PhD, Jordi Esteve, MD, PhD

Blood (2012) 120 (21): 2551.

https://doi.org/10.1182/blood.V120.21.2551.2551

Published: 2012

Journal Articles

Analysis of SF3B1 in a Large Cohort of Refractory Anemia with Ring Sideroblasts with/without Marked Thrombocytosis (RARS-T/RARS) in an European Multicentre Study Reveals a High Incidence (86.3%) of Mutations and an Independent Favorable Association with Outcome

Susanne Schnittger, PhD, Ulrich Germing, Julien Broseus, Vera Grossmann, MSc, Tamara Alpermann, Lourdes Florensa Brichs, MD, Eric Lippert, PhD, Francois Liferman, MD, Sabine Jeromin, PhD, Torsten Haferlach, MD, Francois Girodon, MD, PhD

Blood (2012) 120 (21): 3798.

https://doi.org/10.1182/blood.V120.21.3798.3798

Published: 2012

Journal Articles

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Fernando Ramos, MD, PhD, MPH, Carmen Pedro, Jose-Maria Garcia-Ruiz-de-Morales, Eva Barragan, Raquel de Paz, Andres Insunza, Mar Tormo, Maria Diez-Campelo, Blanca Xicoy, Eduardo Salido, Javier Sanchez-del-Real, Leonor Arenillas, Carlos Santamaria, Noemi Puig, Lourdes Florensa, Francesc Sole, Marcos González, Elisa Luño, Guillermo F Sanz

Blood (2012) 120 (21): 3803.

https://doi.org/10.1182/blood.V120.21.3803.3803

Published: 2012

Journal Articles

Absence of Mutations of the Histone Methyltransferase Gene EZH2 In Splenic B-Cell Marginal Zone Lymphoma

Luz Martínez-Avilés, Marta Salido, Beatriz Bellosillo, Vera Adema, Ana Ferrer, Antonio Salar, Dr., Mar Garcia, Blanca Espinet, Lourdes Florensa, Carles Besses, Sergi Serrano, Francesc Sole

Blood (2010) 116 (21): 5086.

https://doi.org/10.1182/blood.V116.21.5086.5086

Published: 2010

NARROW

Clinical Outcomes and Mutational Profile Associated with Dysmyelopoiesis in Chronic Myelomonocytic Leukemia

Assessment of Dysgranulopoiesis By Optical Cytology Compared to Distribution of Monocyte Subsets By Flow Cytometry in Peripheral Blood for Predicting the Diagnosis of CMML

Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML)

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features

Diagnostic Utility of Flow Cytometric Immunophenotyping in Chronic Myelomonocytic Leukemia

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia

Considering Bone Marrow Blasts from Nonerythroid Cells Improves the Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts

Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Myelodysplastic Syndromes (MDS) with Erythroid Hyperplasia: Enumerating Blasts from Non-Erythroid Cell Compartment Improves the Risk Stratification of MDS with Excess of Blasts

The Complete Mutatome and Clonal Architecture of Del(5q)

RAEB-1 with Erythroid Hyperplasia and Erythroleukemia Share Clinico-Biological Features and Outcome: A Same Disease with Different Labels?

Whole-Exome Sequencing in Myelodysplastic Syndromes with 5q Deletion

Giant multilobated mastocytes (promastocytes) in the setting of a refractory acute myeloid leukemia with myelodysplasia-related changes and monosomal karyotype

Whole-Exome Sequencing In Myelodysplastic Syndromes With 5q- and Normal Karyotype

Multilineage Dysplasia Confers Poor Prognosis to Patients with De Novo Acute Myeloid Leukemia with Intermediate-Risk Cytognetics and Wild-Type NPM1 .

Analysis of SF3B1 in a Large Cohort of Refractory Anemia with Ring Sideroblasts with/without Marked Thrombocytosis (RARS-T/RARS) in an European Multicentre Study Reveals a High Incidence (86.3%) of Mutations and an Independent Favorable Association with Outcome

Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

Absence of Mutations of the Histone Methyltransferase Gene EZH2 In Splenic B-Cell Marginal Zone Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only